Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis
The baseline SV and its relative change at three months after treatment are expected to become routine imaging makers for predicting survival in HCC patients receiving ICIs, which consequently contributes to their clinical management.
Authors
- Quan Chen (ORCID: https://orcid.org/0000-0001-6360-5953)
- Yuxin Sun (ORCID: https://orcid.org/0000-0003-0674-8709)
- Shanshan Jiang (ORCID: https://orcid.org/0000-0003-3461-6076)
- Xiaona Fu
- Sichen Wang (ORCID: https://orcid.org/0009-0002-8492-3234)
- Yanlin Li (ORCID: https://orcid.org/0000-0003-1614-3228)
- Yi Li (ORCID: https://orcid.org/0000-0003-0398-0967)
- Jie Lou (ORCID: https://orcid.org/0009-0006-6064-1450)
- Lian Yang (ORCID: https://orcid.org/0000-0003-4664-2474)
- Yusheng Guo (ORCID: https://orcid.org/0000-0003-2977-9356)
- Yi Ren (ORCID: https://orcid.org/0009-0007-0523-0197)
- Bingxin Gong
Institutions
- Union Hospital (HK)
- Harbin Institute of Technology (CN)
- Precision for Medicine (United States) (US)
- State Key Laboratory of Information Engineering in Surveying Mapping and Remote Sensing (CN)
- The First People's Hospital of Jiangxia District (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jhc.s524483
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.97
Funders
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities